CBIO Stock Analysis: Buy, Sell, or Hold?
CBIO - Crescent Biopharma, Inc. Common Stock
$14.47
-0.55 (-3.66%)
▼
5d:
-11.23%
30d:
-15.28%
90d:
-35.32%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When CBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CBIO is currently trading at $14.47, which is considered oversold relative to its 30-day fair value range of $15.28 to $17.46.
Technical Outlook: Technically, CBIO is showing sideways momentum. Immediate support is located at $13.99, while resistance sits at $17.80. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: CBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $31.00 (+114.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CBIO is showing sideways momentum. Immediate support is located at $13.99, while resistance sits at $17.80. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: CBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $31.00 (+114.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$15.28 -
$17.46
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 114.2% below Wall St target ($31.00)
- CAUTION: 5-day price weakness (-11.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$15.28 -
$17.46
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$13.99
Resistance Level
$17.80
Current Trend
Sideways
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.86
Wall Street Target
$31.00
(+114.2%)
Share & Embed Analysis
Last updated: August 03, 2026 12:58 AM ET
Data refreshes hourly during market hours. Next update: 1:58 AM
Data refreshes hourly during market hours. Next update: 1:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |